Biological membrane derived nanomedicines for cancer therapy
Crossref DOI link: https://doi.org/10.1007/s11426-020-9943-9
Published Online: 2021-04-06
Published Print: 2021-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Lele
Xiong, Zijian
Shen, Fengyun
Wang, Zhanhui
Liu, Zhuang
Text and Data Mining valid from 2021-04-06
Version of Record valid from 2021-04-06
Article History
Received: 8 December 2020
Accepted: 18 January 2021
First Online: 6 April 2021
Ethics
: <b>Conflict of interest</b> The authors declare no conflict of interest.